Author:
Ojero-Senard Ana,Benevent Justine,Bondon-Guitton Emmanuelle,Durrieu Geneviève,Chebane Leila,Araujo Melanie,Montastruc Francois,Montastruc Jean-Louis
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Anderson, I. M., Nutt, D. J. and Deakin, JFW. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology Guidelines. J Psychopharmacol, 2000; 14, 3–20
2. FDA Drug Safety Communication: Revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses. http://www.fda.gov/Drugs/DrugSafety/ucm297391.htm
3. FDA Drug Safety Communication: Clarification of dosing and warning recommendations for Celexa http://www.fda.gov/Drugs/ResourcesForYou/SpecialFeatures/ucm297764.htm
4. Rector TS, Adabag S, Cunningham F, Nelson D, Dieperink E (2016) Outcomes of citalopram dosage risk mitigation in a veteran population. Am J Psychiatry 173:896–902
5. Castro VM, Clements CC, Murphy SN, Gainer VS, Fava M, Weilburg JB, Erb JL, Churchill SE, Kohane IS, Iosifescu DV, Smoller JW, Perlis RH (2013) QT interval and antidepressant use: a cross sectional study of electronic health records. Br Med J 346:f288
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献